Dr John D Completo, MD in Fort Sill,, OK - Preventive Medicine

Dr John D Completo, MD is a Preventive Medicine - Public Health & General Preventive Medicine physician based in Fort Sill,, Oklahoma. Dr John D Completo is licensed to practice in Tennessee (license number MD0000030570) and his current practice location is 4301 Mow-way Road, Reynolds Army Community Hospital (attn: Ms. Prescott), Fort Sill,, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (580) 458-2134.

NPI number for Dr John D Completo is 1629150453 and his current mailing address is 4301 Mow-way Road, Reynolds Army Community Hospital (attn: Ms. Prescott), Fort Sill,, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1629150453.

Contact Information

	Dr John D Completo, MD
	4301 Mow-way Road, Reynolds Army Community Hospital (attn: Ms. Prescott), Fort Sill,, OK 73503-6300
	(580) 458-2134
	(580) 458-2314

Physician's Profile

Full Name	Dr John D Completo
Gender	Male
Speciality	Preventive Medicine - Public Health & General Preventive Medicine
Location	4301 Mow-way Road, Fort Sill,, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1629150453
Provider Enumeration Date: 10/20/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr John D Completo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1629150453	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083P0901X	Preventive Medicine - Public Health & General Preventive Medicine	MD0000030570 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John D Completo is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John D Completo, MD 4301 Mow-way Road, Reynolds Army Community Hospital (attn: Ms. Prescott), Fort Sill,, OK 73503-6300 Ph: (580) 458-2134	Dr John D Completo, MD 4301 Mow-way Road, Reynolds Army Community Hospital (attn: Ms. Prescott), Fort Sill,, OK 73503-6300 Ph: (580) 458-2134

News Archive

Chemed declares 163rd consecutive quarterly dividend

Chemed Corporation announced today that the Board of Directors has declared a quarterly cash dividend of 16 cents per share on the Company's capital stock, payable on March 19, 2012, to shareholders of record as of February 27, 2012.

Milwaukee judge dismisses class action lawsuit against Extendicare

Extendicare Real Estate Investment Trust ("Extendicare REIT") (TSX:EXE.UN) announced that a judge in Milwaukee County Circuit Court ruled that a class action lawsuit brought against Extendicare Health Services, Inc., Extendicare Homes, Inc. and other related entities (collectively "Extendicare"), wholly owned U.S. based subsidiaries of Extendicare REIT, was improper and ordered the case dismissed in its entirety.

FDA grants BSD Medical marketing clearance for MicroThermX Microwave Ablation System

BSD Medical Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market its MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue. Clearance from the FDA of BSD's 510(k) Premarket Notification submission authorizes the commercial sale of the MTX-180 in the United States. The MTX-180 was designed to provide a higher power, optimized system targeted to the growing therapeutic interventional and surgical oncology market.

FDA approves first generic divalproex sodium for the treatment of seizures, bipolar disorder and migraine headaches

The U.S. Food and Drug Administration today approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches.

Sabin Vaccine Institute, Texas Children's Hospital, Baylor College of Medicine to create tropical disease research school

Peter Hotez, chair of the Department of Microbiology, Immunology, and Tropical Medicine at George Washington University and president of Sabin Vaccine Institute, "will join the staffs of Texas Children's Hospital and Baylor College of Medicine this summer, and will serve as founding dean of a new, as yet unnamed, tropical disease research school at Baylor," the Houston Chronicle reports.

Dr John D Completo, MD - Preventive Medicine in Fort Sill,, OK